Article Details

Cogentix Medical (NASDAQ:CGNT) Rating Lowered to Sell at Zacks Investment Research

Retrieved on: 2018-02-17 14:00:00

Tags for this article:

Click the tags to see associated articles and topics

Cogentix Medical (NASDAQ:CGNT) Rating Lowered to Sell at Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Millennium Management LLC now owns 104,343 shares of the medical device company's stock valued at $329,000 after acquiring an additional 19,753 shares during the last quarter. <b>Renaissance Technologies</b> LLC raised its holdings in shares of Cogentix Medical by 12.7% during the fourth quarter.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up